Traditional medicine maker Neautus rises 72% in Hong Kong trading debut
Shares of Sichuan Neautus Traditional Chinese Medicine Co. Ltd. (2206.HK) jumped in their Hong Kong trading debut on Wednesday, as retail investors clamored to buy into China’s largest private producer…
Neautus launches Hong Kong IPO at up to HK$3.3 billion valuation
Sichuan Neautus Traditional Chinese Medicine Co. Ltd. (2206.HK) launched its Hong Kong IPO on Oct. 30, targeting a valuation of up to HK$3.3 billion ($423 million), as it seeks to…
Traditional Chinese medicine leader Yuyantang finds tonic in aging population
The company has filed for a Hong Kong IPO, thriving on China’s growing silver economy and a steady stream of government policies supporting traditional Chinese medicine Key Takeaways: Yuyantang has…
Tong Ren Tang Healthcare makes trading debut, backed by 39% annual patient growth
The company will use a majority of the $68 million it raised from its Hong Kong listing to expand its network of traditional Chinese medicine hospitals and clinics Key Takeaways:…
Tong Ren Tang kicks off IPO leveraging time-honored medicinal brand to offer healthcare
One of China’s oldest medical names has applied to list its Tong Ren Tang Healthcare Investment unit, which is building an integrated healthcare system Key Takeaways: Top-rated non-public traditional Chinese…
Anew Health taps investor ‘Qi’ with Nasdaq listing plan
The Hong Kong-based provider of pain relief services using traditional Chinese principles aims to raise about $7.2 million through its U.S. listing, valuing it at up to $200 million Key…
Neautus looks outward to boost its traditional medicine story
The maker of traditional Chinese medicines has applied for a Hong Kong IPO after abandoning two listing attempts on China’s domestic A-share market Key Takeaways: Neautus has applied to list…